OMB control number
Mailing of Important Information About Drugs
OMB 0910-0754 ยท HHS/FDA.
OMB 0910-0754
This information collection request supports agency regulations at 21 CFR part 200.5 and the associated agency guidance regarding "Dear Healthcare Provider" Letters. Respondents to the collection are manufacturers and distributors of drugs for which such a letter would be required as provided for in our regulations. The letters communicate important information about prescription drug and biological products (drugs).
The latest form for Mailing of Important Information About Drugs expires 2022-12-31 and is listed under ICR 201911-0910-007.
Latest Forms, Documents, and Supporting Material
| Document | Type |
|---|---|
 0754 Dear HCP Letters SSA 2023 Ext.docx | Supporting Statement A |
 Dear Healthcare Provider Letter; Improving Communication of Important Safety Information |
Other-Agency Guidance |
All Historical Document Collections
| Reference | Filing | Received | Concluded | Action |
|---|---|---|---|---|
| 202212-0910-003 | Extension without change of a currently approved collection | 2022-12-19 | Approved without change | |
| 201911-0910-007 | Extension without change of a currently approved collection | 2019-12-06 | Approved without change | |
| 201610-0910-007 | Extension without change of a currently approved collection | 2016-10-24 | Approved without change | |
| 201309-0910-005 | New collection (Request for a new OMB Control Number) | 2013-09-13 | Approved with change |